News

Home/News
News 2018-08-09T15:32:37+00:00
July 23, 2018
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced the achievement of key milestones as ...
July 23, 2018
BioTime to Announce Second Quarter 2018 Results on August 2, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will release second quarter 2018 financial ...
July 23, 2018
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
TEL-AVIV, Israel and RALEIGH, N.C., July 23, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
July 23, 2018
Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
July 23, 2018
STRATA Skin Sciences Announces Licensing Agreement for Certain MelaFind Assets
HORSHAM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
July 23, 2018
BrainStorm Announces Financial Results for the Second Quarter of 2018 and Provides a Corporate Update
NEW YORK and PETACH TIKVAH, Israel, July 23, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
July 20, 2018
PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides
BOSTON--(BUSINESS WIRE)-- PureTech Health to receive up to $36 million in upfront payments, research support, and early preclinical milestones and is eligible to potentially receive ...
July 20, 2018
Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI)
SOUTH SAN FRANCISCO, Calif., July 20, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug ...
July 19, 2018
Aeglea BioTherapeutics Appoints Dr. Anthony G. Quinn as President and Chief Executive Officer
AUSTIN, Texas, July 19, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
July 19, 2018
Inventiva Reports First-half 2018 Financial Results and Provides a Corporate Update
Cash position at €75.9 million as of June 30, 2018 Successful €32.5 million private placement on April 17, 2018 (net proceeds) strengthening the company`s cash ...
July 19, 2018
ArQule to Report Second Quarter 2018 Financial Results on August 1, 2018
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (ARQL) today announced it will report financial results for the second quarter of 2018 before the market opens on Wednesday, August ...
July 19, 2018
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
Basel, Switzerland, July 19, 2018 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that it has received a CHF 2 million milestone payment from its partner ...
July 19, 2018
Allakos Announces Pricing of Initial Public Offering
SAN CARLOS, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- Allakos Inc., (ALLK), a clinical stage biotechnology company focused on the development of antibodies for the ...
July 19, 2018
Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
July 19, 2018
Oncobiologics Completes Exchange of Series A Convertible Preferred Stock for Newly Created Series A-1 Convertible Preferred Stock
CRANBURY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced that, on July 18, 2018, the Company completed the exchange of an ...
July 18, 2018
Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
SOUTH SAN FRANCISCO, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
July 18, 2018
Vermillion to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Thursday, August 9
AUSTIN, Texas, July 18, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will report ...
July 18, 2018
Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy
BUFFALO, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
July 17, 2018
AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares
Lausanne, Switzerland, July 17, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced that it is commencing ...
July 17, 2018
Inspire Medical Systems, Inc. to Report Second Quarter 2018 Financial Results August 7, 2018
MINNEAPOLIS, July 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (“Inspire”) (INSP), a medical technology company focused on the development and commercialization of innovative ...
Page 5 of 95